Basic Information
LncRNA/CircRNA Name | LINC00461 |
Synonyms | NA |
Region | GRCh38_5:88507546-88691041 |
Ensemble | ENSG00000245526 |
Refseq | NR_024384 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | lung adenocarcinoma |
ICD-0-3 | C34 |
Methods | Dual luciferase reporter gene assay, RIP, RT-qPCR, Western blot analysis |
Sample | cell lines(H1299, A549, PC9, LTEP-A-2, NCI-H1650 and MRC-5) |
Expression Pattern | up-regulated |
Function Description | Overexpressed LINC00461 and HOXA10 but down-regulated miR-195 were observed in primary and metastatic lung adenocarcinoma. LINC00461 negatively regulated miR-195, while miR-195 negatively regulated HOXA10. Forced LINC00461 expression decreased expression of miR-195 and Bax, increased expression of HOXA10, MMP-2, MMP-9 and Bcl-2, promoted cell proliferation, migration and invasion as well as tumour formation, and enhanced radiosensitivity of lung adenocarcinoma cells. |
Pubmed ID | 31967713 |
Year | 2020 |
Title | Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195 |
External Links
Links for LINC00461 | GenBank HGNC NONCODE |
Links for lung adenocarcinoma | OMIM COSMIC |